Adcock Ingram Holdings | AIP - Gross Profit On Sales



Adcock Ingram Holdings reported ZAR1.54B in Gross Profit on Sales for its fiscal semester ending in December of 2024.


Gross Profit On Sales Change Date
Adcock Ingram Holdings ZAR 1.54B 73.26M Dec/2024
Alaunos Therapeutics -1127000 1.11M Sep/2024
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Avita Medical AUD 16.13M 3.05M Dec/2024
Dianthus Therapeutics 193K 970K Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Life Healthcare 5.11B 1.04B Sep/2024
Moderna USD 18M 1000K Jun/2025
Netcare ZAR 6.5B 546M Sep/2024
Organon & Co USD 874M 33M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Tectonic Therapeutic 0 0 Mar/2025
Viatris USD 1.33B 98.1M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025